Optimization of atrial defibrillation with a dual-coil, active pectoral lead system

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 7, 2004, Pages 790-794

  Rashba, Eric J ^a   Shorofsky, Stephen R ^a   Peters, Robert W ^a   Gold, Michael R ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Atrial fibrillation; Defibrillation threshold; Implantable cardioverter defibrillator

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; ELECTRIC CURRENT; ENERGY TRANSFER; FEMALE; HEART ATRIUM FIBRILLATION; HEART RIGHT VENTRICLE; HUMAN; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PULSE GENERATOR; RANDOMIZED CONTROLLED TRIAL; SUPERIOR CAVA VEIN;

AGED; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 3242677680     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03684.x     Document Type: Article

References (29)

1. Grimm W, Flores B, Marchlinski F: Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillators. Am J Cardiol 1993;71:1415-1418.
2. Kelly PA, Mann DE, Reiter MJ, Harken AH: Atrial fibrillation after implantable cardioverter-defibrillator implantation. Pacing Clin Electrophysiol 1995;18:379-385.
3. Gronefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH: Association between atrial fibrillation and appropriate implantable cardioverter- defibrillator therapy: Results from a prospective study. J Cardiovasc Electrophysiol 2000;11:1208-1214.
4. Stein KM, Euler DE, Mehra R, Seidl K, Slotwiner DJ, Mittal S, Markowitz SM, Lerman BB, for the Jewel AF Worldwide Investigators: Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? J Am Coll Cardiol 2002;40:335-340.
5. Middlekauff HR, Stevenson WG, Stevenson LW: Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-48.
6. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW: Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. J Am Coll Cardiol 1998;32:695-703.
7. The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
8. Daoud EG, Timmermans C, Fellows C, Hoyt R, Lemery R, Dawson K, Ayers GM, for the Metrix Investigators: Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Circulation 2000;102:1407-1413.
9. Wellens HJJ, Lau CP, Luderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G: Atrioverter: An implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-1656.
10. Gold MR, Sulke N, Schwartzman DS, Mehra R, Euler DE, for the Worldwide Jewel AF-Only Investigators: Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial arrhythmias. J Cardiovasc Electrophysiol 2001;12:1247-1253.
11. Swerdlow CD, Schwartzman D, Hoyt R, Bailin SJ, Koehler JL, Warman EN, for the Worldwide Model 7250 Jewel AF-Only Investigators: Determinants of first-shock success for atrial implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2002;13:347-354.
12. Boriani G, Wollman C, Biffi M, Kuhl M, Schuchert A, Sperzel J, Stiller S, Gasparini G, Bocker D: Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias. Pacing Clin Electrophysiol 2003;26(Pt II):461-465.
13. Cooklin M, Olsovsky MR, Brockman RG, Shorofsky SR, Gold MR: Atrial defibrillation with a transvenous lead. A randomized comparison of active can shocking pathways. J Am Coll Cardiol 1999;34:358-362.
14. Gold MR, Shorofsky SR, Bouhouch R, Joy RA, Kirby DS, Osman AF, Rashba EJ: Lack of benefit of an active pectoral pulse generator on atrial defibrillation thresholds. J Cardiovasc Electrophysiol 2002;13:332-335.
15. Bardy GH, Johnson G, Poole JE, Dolack GL, Kudenchuk PJ, Kelso D, Mitchell R, Mehra R, Hofer B: A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543-547.
16. Gold MR, Olsovsky MR, Pelini MA, Peters RW, Shorofsky SR: A comparison of single and dual coil active pectoral defibrillation lead systems. J Am Coll Cardiol 1998;31:1391-1394.
17. Cooper RA, Johnson EE, Wharton JM: Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms: The importance of phase duration. Circulation 1997;95:1487-1496.
18. Cooper RAS, Plumb VJ, Epstein AE, Kay NG, Ideker RE: Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans. Circulation 1998;97:2527-2535.
19. Benser ME, Walcott GP, Killingsworth CR, Girouard SD, Morris MM, Ideker RE: Atrial defibrillation thresholds of electrode configurations available to an atrioventricular defibrillator. J Cardiovasc Electrophysiol 2001;12:957-964.
20. Tse HF, Timmermans C, Rodriguez L-M, Lau C-P, Wellens HJJ: Effect of coronary sinus electrode on the optimal atrial defibrillation pathway for an atrioventricular defibrillator. J Cardiovasc Electrophysiol 2003;14:32-37.
21. Steinhaus DM, Cardinal DS, Mongeon L, Musley SK, Foley L, Corrigan S: Internal defibrillation: pain perception of low energy shocks. Pacing Clin Electrophysiol 2002;25:1090-1093.
22. Timmermans C, Rodriguez L-M, Ayers GM, Lambert H, Smeets JLRM, Vlaeyen JWS, Albert A, Wellens HJJ: Effects of butorphanol tartrate on shock-related discomfort during internal atrial defibrillation. Circulation 1999;99:1837-1842.
23. Shorofsky SR, Gold MR: Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol 1996;78:313-316.
24. Lau CP, Nok NS: A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation. Pacing Clin Electrophysiol 1997;20:2442-2452.
25. Timmermans C, Rodriguez L-M, Ayers GM, Lambert H, Smeets JLRM, Wellens HJJ: Effect of electrode length on atrial defibrillation thresholds. J Cardiovasc Electrophysiol 1998;9:582-587.
26. Strickberger SA, Man KC, Souza J, Zivin A, Weiss R, Knight BP, Goyal R, Daoud EG, Morady F: A prospective evaluation of two defibrillation safety margin techniques in patients with low defibrillation energy requirements. J Cardiovasc Electrophysiol 1998;9:41-46.
27. Singer I, Lang D: Defibrillation threshold: Clinical utility and therapeutic implications. Pacing Clin Electrophysiol 1992;15:932-949.
28. McDaniel WC, Schuder JC: The cardiac ventricular defibrillation threshold-inherent limits in its application and interpretation. Med Instrum 1987;21:170-176.
29. Boriani G, Bartolini P, Biffi M, Calcagnini G, Camanini C, Corazza I, Zannoli R, Barbaro V, Branzi A: Atrial signal analysis and defibrillation threshold assessment in chronic persistent and reinduced atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:449-454.